Mark Perry Net Worth & Insider Trades
Mark Perry - Director, Global Blood Therapeutics, Inc
What is Mark Perry's Net Worth?
The current estimated net worth of Global Blood Therapeutics, Inc's Director, Mark Perry, is estimated to be about $73.26M . Mark Perry owns about 26,428 units of Global Blood Therapeutics, Inc common stock. In the last 7 years at Global Blood Therapeutics, Inc, Mark Perry has sold an estimated value of $4.19M worth.
What is Mark Perry's Past Insider Trading?
Mark Perry's largest purchase order was 53,600 units , worth over $1.18M on May 13, 2020. Mark Perry's largest sale order was 53,600 units , worth over $4.19M on May 13, 2020. In total, Mark Perry has made about 11 transactions over 7 years of their time at Global Blood Therapeutics, Inc. Mark Perry usually trades in June, with the busiest year in 2016, 2022 and 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MARK PERRY
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Mark Perry's' Mailing Address?
- Mailing address is 176 West Blithedale Ave Mill Valley CA 94941 CA
Global Blood Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Ted Love, M.D. | 2020 | $661,250 | - | $11,778,840 | $4,693,666 | $467,000 | $5,000 | $17,605,756 |
Ted Love, M.D. | 2019 | $596,876 | - | $4,359,600 | $4,595,717 | $540,000 | $5,000 | $10,097,193 |
Ted Love, M.D. | 2018 | $568,750 | - | $4,648,800 | $4,623,690 | $414,000 | $5,000 | $10,260,240 |
David Johnson | 2020 | $463,750 | - | $4,037,361 | $1,582,504 | $234,000 | $5,000 | $6,322,615 |
David Johnson | 2019 | $453,125 | - | $1,211,000 | $1,267,784 | $250,000 | $5,000 | $3,186,909 |
David Johnson | 2018 | $355,000 | $75,000 | $1,897,750 | $1,898,534 | $169,000 | $5,000 | $4,394,284 |
Jeffrey Farrow | 2020 | $457,813 | - | $3,708,261 | $1,582,504 | $231,500 | $5,000 | $5,985,078 |
Jeffrey Farrow | 2019 | $440,625 | - | $1,211,000 | $1,267,784 | $244,000 | $5,000 | $3,168,409 |
Jeffrey Farrow | 2018 | $425,938 | - | $1,370,800 | $1,326,469 | $201,000 | $5,000 | $3,329,207 |
Jung Choi | 2020 | $433,125 | - | $3,708,261 | $1,582,504 | $219,000 | $5,000 | $5,947,890 |
Jung Choi | 2019 | $416,875 | - | $1,211,000 | $1,267,784 | $231,000 | $5,000 | $3,131,659 |
Jung Choi | 2018 | $392,063 | - | $1,370,800 | $1,326,469 | $185,000 | $5,000 | $3,279,332 |
Tricia Suvari | 2020 | $422,499 | - | $3,708,261 | $1,582,504 | $214,000 | $5,000 | $5,932,264 |
Tricia Suvari | 2019 | $403,125 | - | $1,211,000 | $1,267,784 | $223,000 | $5,000 | $3,109,909 |
Tricia Suvari | 2018 | $386,875 | - | $1,549,600 | $1,515,964 | $183,000 | $5,000 | $3,640,439 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1629137/000119312521136815/d97499ddef14a.htm
What are Global Blood Therapeutics, Inc's Past Insider Trades?
Global Blood Therapeutics, Inc's most recent insider trade came on September 6, 2022 by Jeffrey Farrow who sold 33,326 units worth $2.27M . In the last 7 years, insiders at Global Blood Therapeutics, Inc have sold an estimated value of $167.81M and bought an estimated value of $17.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jung Choi, See Remarks, Ted Love, President and CEO, and Borga Tricia Suvari, Chief Legal Officer .
Global Blood Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |